Trans-spectral organic dye laser photocoagulation.
Clinical research utilizing the yellow, orange, and red wavelengths of the dye laser (Rhodamine 6G and MD-631) appears to have considerable promise and may demonstrate that the liquid organic dye laser is the laser of choice for photocoagulation of many types of ocular defects. The effectiveness of the dye laser as a photocoagulation source is due to the trans-spectral availability of relatively high output power wavelengths. Therefore, a target tissue can be selectively coagulated with minimal laser energy transmitted through the refractive media and minimal damage to nearby normal tissues. The dye laser, as a photocoagulation system, should prove valuable in the therapy of many ocular diseases.
F A
FA
L'Esperance
D000798:Angiomatosis / Q000175:diagnosis / Q000601:surgery; D002830:Choroid Neoplasms / Q000175:diagnosis / Q000601:surgery; D004396:Coloring Agents; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000601:surgery; D005134:Eye Neoplasms / Q000175:diagnosis / Q000601:surgery; D005451:Fluorescein Angiography; D006391:Hemangioma / Q000175:diagnosis / Q000601:surgery; D006801:Humans; D053685:Laser Therapy; D008028:Light Coagulation / Q000379:methods*; D008268:Macular Degeneration / Q000175:diagnosis / Q000601:surgery; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000601:surgery; D012164:Retinal Diseases / Q000175:diagnosis / Q000601:surgery; D012169:Retinal Vein; D012171:Retinal Vessels; D012235:Rhodamines; D013194:Staining and Labeling; D014966:Xanthenes
D004396:Coloring Agents; D012235:Rhodamines; D014966:Xanthenes; C026188:rhodamine 6G